JPS61280429A - 免疫抑制剤 - Google Patents

免疫抑制剤

Info

Publication number
JPS61280429A
JPS61280429A JP60121518A JP12151885A JPS61280429A JP S61280429 A JPS61280429 A JP S61280429A JP 60121518 A JP60121518 A JP 60121518A JP 12151885 A JP12151885 A JP 12151885A JP S61280429 A JPS61280429 A JP S61280429A
Authority
JP
Japan
Prior art keywords
prodigiosin
immunosuppressant
metacycloprodigiosin
cells
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60121518A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0586374B2 (de
Inventor
Gakuzo Tamura
田村　學造
Kazuo Nagai
和夫 永井
Akito Nakamura
明人 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP60121518A priority Critical patent/JPS61280429A/ja
Publication of JPS61280429A publication Critical patent/JPS61280429A/ja
Publication of JPH0586374B2 publication Critical patent/JPH0586374B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP60121518A 1985-06-06 1985-06-06 免疫抑制剤 Granted JPS61280429A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60121518A JPS61280429A (ja) 1985-06-06 1985-06-06 免疫抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60121518A JPS61280429A (ja) 1985-06-06 1985-06-06 免疫抑制剤

Publications (2)

Publication Number Publication Date
JPS61280429A true JPS61280429A (ja) 1986-12-11
JPH0586374B2 JPH0586374B2 (de) 1993-12-10

Family

ID=14813198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60121518A Granted JPS61280429A (ja) 1985-06-06 1985-06-06 免疫抑制剤

Country Status (1)

Country Link
JP (1) JPS61280429A (de)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017381A1 (en) * 1993-12-23 1995-06-29 Pharmacia S.P.A. Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity
WO1998040380A1 (en) * 1997-03-11 1998-09-17 Pharmacia & Upjohn S.P.A. Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
WO1999015690A1 (en) * 1997-09-20 1999-04-01 Korea Institute Of Science And Technology Novel serratia marcescens strain, prodigiosin and the use of the same as an immunosuppressive
WO2001055131A3 (en) * 2000-01-26 2002-03-07 Gemin X Biotechnologies Inc Prodigiosin-derivatives as neoplastic and anti-viral agents
WO2002085350A1 (en) * 2001-04-19 2002-10-31 Korea Research Institute Of Bioscience And Biotechnology Prodigiosin composition for the treatment of rheumatic arthritis
US7144912B2 (en) 2001-07-18 2006-12-05 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
US7491745B2 (en) 2000-01-26 2009-02-17 Gemin X Pharmaceuticals Canada Inc. Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120153C (zh) * 1993-12-23 2003-09-03 法玛西雅厄普约翰公司 亚吡咯基甲基衍生物及其制备方法
WO1995017381A1 (en) * 1993-12-23 1995-06-29 Pharmacia S.P.A. Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity
EP1241162A1 (de) * 1993-12-23 2002-09-18 Pharmacia Italia S.p.A. 2,2'-bi-1H-pyrrole-derivate mit immunsuppressiver wirkund
WO1998040380A1 (en) * 1997-03-11 1998-09-17 Pharmacia & Upjohn S.P.A. Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
WO1999015690A1 (en) * 1997-09-20 1999-04-01 Korea Institute Of Science And Technology Novel serratia marcescens strain, prodigiosin and the use of the same as an immunosuppressive
US6645962B1 (en) * 1997-09-20 2003-11-11 Korea Research Institute Of Bioscience And Biotechnology Process of using prodigiosin as an immunosuppressive
WO2001055131A3 (en) * 2000-01-26 2002-03-07 Gemin X Biotechnologies Inc Prodigiosin-derivatives as neoplastic and anti-viral agents
US6602879B2 (en) 2000-01-26 2003-08-05 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
EP1431286A2 (de) * 2000-01-26 2004-06-23 Gemin X Biotechnologies Inc. Prodigiosinderivate zur Behandlung von Krebs- und Virus-Erkrankungen
EP1431286A3 (de) * 2000-01-26 2004-07-28 Gemin X Biotechnologies Inc. Prodigiosinderivate zur Behandlung von Krebs- und Virus-Erkrankungen
US7491745B2 (en) 2000-01-26 2009-02-17 Gemin X Pharmaceuticals Canada Inc. Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease
WO2002085350A1 (en) * 2001-04-19 2002-10-31 Korea Research Institute Of Bioscience And Biotechnology Prodigiosin composition for the treatment of rheumatic arthritis
US7144912B2 (en) 2001-07-18 2006-12-05 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression

Also Published As

Publication number Publication date
JPH0586374B2 (de) 1993-12-10

Similar Documents

Publication Publication Date Title
JPS62277321A (ja) Ｆｒ―９００５０６物質の固形医薬製剤用固溶体組成物
KR20190111133A (ko) 전립선암 치료용 조합, 약학 조성물 및 치료 방법
JP5590286B2 (ja) 新規なＣａ２＋シグナル伝達阻害剤
JP2009512691A (ja) クロストリジウムディフィシレ関連の下痢の治療方法
FR2527441A1 (fr) Agent pour accroitre l'activite antitumorale d'un agent antitumoral et composition antitumorale le contenant
WO1997039999A1 (fr) Nouveaux composes de terphenyl et medicaments contenant ces composes
JPS61280429A (ja) 免疫抑制剤
MXPA97002926A (en) La-eritrosis nucleosi
CN110981888B (zh) N-芳基二硫吡咯酮脲类和氨基酯类衍生物及其制备和应用
JP3949196B2 (ja) 免疫抑制剤
CN108440446B (zh) 含有肟基片段的苯并噻嗪-4-酮类化合物及其制备方法
CH646059A5 (fr) Compositions antibiotiques contenant un macrolide et un aminoheteroside.
US8168622B2 (en) β-lactamase-resistant cephalosporin ester compounds and salts of thereof
KR100674222B1 (ko) 세라시아 마르세센스 ｂ-1231 ｋｃｔｃ 0386ｂｐ로부터분리한 프로디지오신을 유효성분으로 포함한 급성이식편대숙주병의 예방 및 치료용 조성물
JPH11302191A (ja) ハタケシメジ抽出物を活性成分とする免疫賦活剤及び抗腫瘍剤
CN110384694B (zh) 一种xenicane型二萜化合物在制备抗氧化神经保护药物中的应用
CN114181225B (zh) 一种含笑内酯衍生物及其药物组合物、制备方法和用途
JP2001515861A (ja) 抗腫瘍薬としてのジチオロピロロンおよびそれらの対応するモノオキサイドおよびジオキサイド
EP1421942A1 (de) Verwendung von Glyzyrrhizin und Derivate als RANTES-Induktoren
CN108976279B (zh) 茶氨酰氨基酸苄酯修饰的姜黄素，其合成，活性和应用
JPH0481593B2 (de)
JP3040699B2 (ja) 毒性軽減剤
CN102503954B (zh) 咪唑衍生物、其制备方法和用途
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
CN117942324A (zh) 酚类化合物在抑制细胞铁死亡和防治铁死亡相关疾病中的应用

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term